Participants were randomly assigned to three groups receiving the following : ( 1 ) folate-1 : 1mg/d folate supplements ( N = 23 ) ; ( 2 ) folate-5 : 5mg/d folate supplements ( N = 23 ) and ( 3 ) placebo ( N = 23 ) for 8weeks .